Physical Exercise Augmented CBT for GAD

NCT02690441 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2026-04-28

No results posted yet for this study

Summary

Generalised anxiety disorder (GAD) is a severe and debilitating anxiety disorder that is highly prevalent among older adults. Anxiety and GAD is a well-documented risk factor for the development of other severe conditions such as depression and dementia, and effective treatments are called for. However, recommended treatment for GAD has consistently been found to yield blunted response rates for older adults compared to younger patients.

The purpose of this study is to evaluate the effects of exercise-augmented cognitive behaviour therapy for older adults with GAD. Exercise augmented CBT is expected to yield better results than standard CBT in terms of greater reduction of symptoms and increased rates of remission. The investigators will also investigate the effects of treatment on biological, physiological and neuropsychological measures.

Conditions

Interventions

BEHAVIORAL

Cognitive Behavioural Therapy

Cognitive behavioural therapy conducted individually. 10 weekly sessions, first session lasts 90 minutes, the remaining sessions last 45 minutes.

BEHAVIORAL

Physical Exercise

Manualised exercise. 15 weekly sessions with instructor, and two weekly unsupervised sessions performed individually.

BEHAVIORAL

Placebo control

One follow-up telephone call à 15 minutes each week for 15 weeks. Aims to control for therapist contact in physical exercise condition and total duration of treatment.

Sponsors & Collaborators

  • University of Bergen

    collaborator OTHER
  • Norwegian University of Science and Technology

    collaborator OTHER
  • University of Oslo

    collaborator OTHER
  • University of California, Berkeley

    collaborator OTHER
  • William Paterson University of New Jersey

    collaborator OTHER
  • Ohio State University

    collaborator OTHER
  • Solli Distriktspsykiatriske Senter

    lead OTHER

Principal Investigators

  • Anders Hovland, PhD · Solli DPS, University of Bergen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2023-10-31
Completion
2026-12-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02690441 on ClinicalTrials.gov